SCHEMBL24987828

SCHEMBL24987828

c1ccc(-n2c3ccccc3c3ccc(-c4ccc5c(c4)c4ccccc4n5-c4ccc5c(c4)c4ccccc4n5-c4ccc([Si](c5ccccc5)(c5ccccc5)c5ccccc5)cc4)cc32)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ATM Q13315 1/20 0.47
PTGER4 P35408 1/20 0.36
HDAC4 P56524 1/20 0.35
RAC2 P15153 1/20 0.34
RAC3 P60763 1/20 0.34
CDC42 P60953 1/20 0.34
RAC1 P63000 1/20 0.34
PTPN1 P18031 2/20 0.33
EDNRB P24530 1/20 0.33
EDNRA P25101 1/20 0.33
TSPO P30536 1/20 0.33
KMT2A Q03164 2/20 0.33
IL1R1 P14778 1/20 0.33
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24987606 1.00 L3MBTL1 (0.47) L3MBTL1KDM4EATMPTGER4HDAC4
SCHEMBL24987610 0.99 L3MBTL1 (0.49) L3MBTL1KDM4EATMPTGER4HDAC4
SCHEMBL24985665 0.97 L3MBTL1 (0.47) L3MBTL1KDM4EATMPTGER4HDAC4
SCHEMBL24987831 0.97 L3MBTL1 (0.47) L3MBTL1KDM4EATMPTGER4HDAC4
SCHEMBL24985669 0.96 L3MBTL1 (0.49) L3MBTL1KDM4EATMPTGER4HDAC4
SCHEMBL24988406 0.96 L3MBTL1 (0.51) L3MBTL1KDM4EATMPTGER4HDAC4
SCHEMBL24987809 0.95 L3MBTL1 (0.45) L3MBTL1KDM4EATMPTGER4HDAC4
SCHEMBL24987556 0.95 L3MBTL1 (0.45) L3MBTL1KDM4EATMPTGER4HDAC4
SCHEMBL24987688 0.95 L3MBTL1 (0.44) L3MBTL1KDM4EATMPTGER4HDAC4
SCHEMBL24089306 0.95 L3MBTL1 (0.44) L3MBTL1KDM4EATMPTGER4HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230019868-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230019868-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE CYP1A1, AOX1, ODC1 L3MBTL1 950/4885KDM4E 3300/4885ATM 3528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.